Published in Br J Dermatol on September 01, 2004
The desmosome and pemphigus. Histochem Cell Biol (2008) 1.54
Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol (2006) 1.45
Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem (2008) 1.43
Pemphigus autoimmunity: hypotheses and realities. Autoimmunity (2011) 1.23
Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol (2008) 1.05
Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS One (2012) 0.99
Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus. Am J Pathol (2005) 0.96
Antimitochondrial autoantibodies in pemphigus vulgaris: a missing link in disease pathophysiology. J Biol Chem (2009) 0.94
Protective endogenous cyclic adenosine 5'-monophosphate signaling triggered by pemphigus autoantibodies. J Immunol (2010) 0.91
MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris. J Invest Dermatol (2013) 0.90
Desmosomes in vivo. Dermatol Res Pract (2010) 0.89
The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting? Am J Pathol (2011) 0.87
Desmosomes in acquired disease. Cell Tissue Res (2015) 0.83
An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol (2011) 0.81
Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris. Clin Exp Immunol (2010) 0.81
Cell adhesion in epidermal development and barrier formation. Curr Top Dev Biol (2015) 0.77
Tyrosine kinases in inflammatory dermatologic disease. J Am Acad Dermatol (2010) 0.76
Crosstalk between Signaling Pathways in Pemphigus: A Role for Endoplasmic Reticulum Stress in p38 Mitogen-Activated Protein Kinase Activation? Front Immunol (2017) 0.75
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
Pemphigus: is there another half of the story? J Invest Dermatol (2001) 2.22
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest (1993) 2.19
Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol (1992) 1.99
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med (1989) 1.88
Complete bundle branch block as an independent predictor of all-cause mortality: report of 7,073 patients referred for nuclear exercise testing. Am J Med (2001) 1.84
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis (1997) 1.75
Isolation of a Bacterial Culture That Degrades Methyl t-Butyl Ether. Appl Environ Microbiol (1994) 1.70
A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol (1985) 1.67
The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med (2000) 1.58
Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol (1997) 1.56
The role of complement in experimental bullous pemphigoid. J Clin Invest (1995) 1.55
A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest (1997) 1.53
Vegetating iododerma with underlying systemic diseases: report of three cases. J Am Acad Dermatol (1990) 1.48
Behçet's disease. Int J Dermatol (1984) 1.45
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol (1993) 1.44
D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol (1997) 1.43
The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol (2003) 1.43
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest (2001) 1.42
Fixed drug eruption secondary to ondansetron. Dermatology (1995) 1.41
Successful treatment of lichen planus with sulfasalazine in 20 patients. Int J Dermatol (2005) 1.37
Pemphigoid and pemphigus antigens in cultured epidermal cells. Br J Dermatol (1978) 1.32
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol (1999) 1.30
Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol (1997) 1.26
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest (1991) 1.21
Isolation of pemphigus antigen from human saliva. J Immunol (1980) 1.20
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia (2011) 1.18
Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest (1990) 1.16
Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest (1988) 1.14
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest (2000) 1.12
Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Immunol Immunopathol (1997) 1.05
Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol (1996) 1.04
Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum (1996) 1.02
The use of human pemphigoid autoantibodies to study the fate of epidermal basal cell hemidesmosomes after trypsin dissociation. J Invest Dermatol (1985) 1.01
Bacteroides fragilis meningitis in a neonate successfully treated with metronidazole. J Pediatr (1978) 1.00
A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol (1997) 1.00
A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex. Biochemistry (1997) 0.99
Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol (1997) 0.99
Tyrosine phosphorylation of human keratinocyte beta-catenin and plakoglobin reversibly regulates their binding to E-cadherin and alpha-catenin. J Invest Dermatol (2001) 0.99
Genomic organization of collagenous domains and chromosomal assignment of human 180-kDa bullous pemphigoid antigen-2, a novel collagen of stratified squamous epithelium. J Biol Chem (1991) 0.98
Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol (1989) 0.98
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. J Invest Dermatol (1995) 0.97
An active focus of high prevalence of fogo selvagem on an Amerindian reservation in Brazil. Cooperative Group on Fogo Selvagem Research. J Invest Dermatol (1996) 0.97
Reliability assessment in advanced nanocomposite materials for orthopaedic applications. J Mech Behav Biomed Mater (2010) 0.97
Mechanism of insulin incorporation into alpha 2-macroglobulin: implications for the study of peptide and growth factor binding. Biochemistry (1991) 0.96
HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics (1991) 0.95
Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol (1984) 0.94
Bullous pemphigoid antigen. II. Isolation from the urine of a patient. J Immunol (1979) 0.94
The hemidesmosomal plaque. I. Characterization of a major constituent protein as a differentiation marker for certain forms of epithelia. Differentiation (1990) 0.94
Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. J Immunol (1995) 0.93
Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol (1985) 0.93
Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest (1981) 0.92
Inducible nitric oxide synthase in human lymphomononuclear cells activated by synthetic peptides derived from extracellular matrix proteins. FEBS Lett (1995) 0.92
Photo-induced toxic epidermal necrolysis caused by clobazam. Br J Dermatol (1996) 0.91
Serologic abnormalities in patients with endemic pemphigus foliaceus (Fogo selvagem), their relatives, and normal donors from endemic and non-endemic areas of Brazil. J Invest Dermatol (1988) 0.91
Endemic pemphigus foliaceus (fogo selvagem)--1998. The Cooperative Group on Fogo Selvagem Research. Clin Dermatol (1999) 0.91
Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. J Exp Med (1997) 0.91
Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett (2004) 0.90
Phylogenetic studies with pemphigus and pemphigoid antibodies. Acta Derm Venereol (1978) 0.90
Pemphigus and pemphigoid antigens are expressed in human amnion epithelium. J Invest Dermatol (1984) 0.90
Herpes gestationis. Clin Dermatol (2001) 0.89
p38 MAPK mediates the regulation of alpha1(I) procollagen mRNA levels by TNF-alpha and TGF-beta in a cell line of rat hepatic stellate cells(1). FEBS Lett (2002) 0.89
Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol (1994) 0.89
Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol (1983) 0.89
A sensitive and specific assay to detect Ro(SS-A) and La(SS-B) antibodies. J Invest Dermatol (1986) 0.89
Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol (1986) 0.89
Pathogenesis of scleroderma. Current concepts. Int J Dermatol (1984) 0.89
Separation of epidermis from dermis with sodium thiocyanate. J Invest Dermatol (1977) 0.88
Characterization of a novel keratinocyte ubiquitin carrier protein. J Biol Chem (1996) 0.88
[Usefulness of bilateral sympathectomy using video-assisted thorascopic surgery in the treatment of essential hyperhidrosis]. Actas Dermosifiliogr (2008) 0.88
[Waldenström macroglobulinemia associated with cutaneous lesions and type I cryoglobulinemia]. Actas Dermosifiliogr (2008) 0.88
Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: the result of hemidesmosome staining. J Am Acad Dermatol (1987) 0.86
Staphylococcus aureus genomic pattern and atopic dermatitis: may factors other than superantigens be involved? Eur J Clin Microbiol Infect Dis (2013) 0.86
Receptor-recognized alpha 2-macroglobulin-methylamine elevates intracellular calcium, inositol phosphates and cyclic AMP in murine peritoneal macrophages. Biochem J (1993) 0.86
Animal models for bullous pemphigoid. Clin Dermatol (1987) 0.86
Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J Invest Dermatol (1999) 0.86
The pattern of expression of CD147/neurothelin during human T-cell ontogeny as defined by the monoclonal antibody 8D6. Tissue Antigens (1997) 0.85
Langerhans' cell histiocytosis on the vulva. Gynecol Oncol (2000) 0.85
UVB-induced acantholysis in endemic Pemphigus foliaceus (Fogo selvagem) and Pemphigus vulgaris. J Am Acad Dermatol (2000) 0.85
An autoantibody in pemphigus serum, specific for the 59 kD keratin, selectively binds the surface of keratinocytes: evidence for an extracellular keratin domain. J Invest Dermatol (1987) 0.85
Atypical atrial flutter originating in the right atrial free wall. Circulation (2000) 0.84
Pregnant women with endemic pemphigus foliaceus (Fogo Selvagem) give birth to disease-free babies. J Invest Dermatol (1992) 0.84
Endemic pemphigus foliaceus in western Parana, Brazil (1976-1988). Cooperative Group for Fogo Selvagem Research. Br J Dermatol (1990) 0.84
Suppressor cell function is preserved in pemphigus and pemphigoid. J Invest Dermatol (1982) 0.84
The human 4F2 antigen: evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell Immunol (1994) 0.84
Pemphigus foliaceus antigen: characterization of an immunoreactive tryptic fragment from BALB/c mouse epidermis recognized by all patients' sera and major autoantibody subclasses. Clin Immunol Immunopathol (1990) 0.84
Cutaneous nocardiosis and human immunodeficiency virus infection. Int J Dermatol (1991) 0.84
Endemic pemphigus foliaceus. Fogo selvagem. Dermatol Clin (1993) 0.84
Pemphigus foliaceus sera recognize an N-terminal fragment of bovine desmoglein 1. J Invest Dermatol (1994) 0.84